BNB PLUS CORP. (BNBX)
BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments. Its Therapeutic DNA Production Services division specializes in the enzymatic manufacturing of synthetic DNA, used in the creation of nucleic acid-based treatments, and also develops and markets its proprietary RNA Polymerase (RNAP) for mRNA therapeutic production. The MDx Testing Services segment concentrates on developing clinical molecular diagnostic and genetic assessments, in addition to providing comprehensive clinical laboratory testing services. Lastly, the DNA Tagging and Security Products and Services segment leverages DNA detection techniques for securing industrial supply chains and offering various security solutions.
Sector: Finance Services
Industry: Biotechnology
BNB Plus Corp.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 6.20M shares outstanding
USBNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA).
The company's operations are divided into three distinct business segments.
Its Therapeutic DNA Production Services division specializes in the enzymatic manufacturing of synthetic DNA, used in the creation of nucleic acid-based treatments, and also develops and markets its proprietary RNA Polymerase (RNAP) for mRNA therapeutic production. The MDx Testing Services segment concentrates on developing clinical molecular diagnostic and genetic assessments, in addition to providing comprehensive clinical laboratory testing services. Lastly, the DNA Tagging and Security Products and Services segment leverages DNA detection techniques for securing industrial supply chains and offering various security solutions.
Leadership
Judith Murrah
Director, Strategic Transition Advisor & Secretary
Clay Shorrock
President & Chief Executive Officer
Beth Jantzen
Chief Financial Officer
Patrick Brian Horsman
Chief Investment Officer
Employees
46
Country
US
Sector
Healthcare
Website
bnbx.io
Loading congressional disclosures…
based on 6.20M shares outstanding
US30d Avg
20.33K
60d Avg
22.49K
90d Avg
39.13K